194 related articles for article (PubMed ID: 7820779)
1. Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption.
Jablonski G; Danielsen CC; Mosekilde L; Gordeladze JO
Calcif Tissue Int; 1994 Oct; 55(4):281-7. PubMed ID: 7820779
[TBL] [Abstract][Full Text] [Related]
2. Aluminium-induced bone disease in uremic rats: effect of deferoxamine.
Jablonski G; Klem KH; Danielsen CC; Mosekilde L; Gordeladze JO
Biosci Rep; 1996 Feb; 16(1):49-63. PubMed ID: 8861540
[TBL] [Abstract][Full Text] [Related]
3. Surgically induced uremia in rats. I: Effect on bone strength and metabolism.
Jablonski G; Klem KH; Attramadal A; Dahl E; Rønningen H; Gautvik KM; Haug E; Gordeladze JO
Biosci Rep; 1993 Oct; 13(5):275-87. PubMed ID: 8142613
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats.
Jablonski G; Mortensen BM; Klem KH; Mosekilde L; Danielsen CC; Gordeladze JO
Calcif Tissue Int; 1995 Nov; 57(5):385-91. PubMed ID: 8564802
[TBL] [Abstract][Full Text] [Related]
5. Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia.
Ishii H; Wada M; Furuya Y; Nagano N; Nemeth EF; Fox J
Bone; 2000 Feb; 26(2):175-82. PubMed ID: 10678413
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. PTH-stimulated adenylate cyclase activity and bone histomorphometry in iliac crest biopsies in the evaluation of uremic patients: a pilot study with the use of artificial intelligence.
Jablonski G; Nordahl K; Halse J; Dahl E; Aksnes L; Gautvik KM; Gordeladze JO
Miner Electrolyte Metab; 1993; 19(6):351-61. PubMed ID: 8164616
[TBL] [Abstract][Full Text] [Related]
8. 24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients.
Mortensen BM; Aarseth HP; Ganss R; Haug E; Gautvik KM; Gordeladze JO
Bone; 1993; 14(2):125-31. PubMed ID: 8334029
[TBL] [Abstract][Full Text] [Related]
9. Zinc nutritional status modifies renal osteodystrophy in uremic rats.
Kimmel PL; Langman CB; Bognar B; Faugere MC; Chawla LS; Watkins DW; Malluche HH
Clin Nephrol; 2001 Dec; 56(6):445-58. PubMed ID: 11770796
[TBL] [Abstract][Full Text] [Related]
10. [Chronic renal insufficiency and secondary hyperparathyroidism in rats. Biochemical and histological evaluation].
Virgós MJ; Menéndez-Rodríguez P; Serrano M; González-Carcedo A; Braga S; Cannata JB
Rev Esp Fisiol; 1993 Dec; 49(4):241-7. PubMed ID: 8209101
[TBL] [Abstract][Full Text] [Related]
11. Role of dietary phosphorus and degree of uremia in the development of renal bone disease in rats.
Oste L; Behets GJ; Dams G; Bervoets AR; Marynissen RL; Geryl H; Van Hoof VO; De Broe ME; D'Haese PC
Ren Fail; 2007; 29(1):1-12. PubMed ID: 17365904
[TBL] [Abstract][Full Text] [Related]
12. Effect of sevelamer hydrochloride on bone in experimental uremic rats.
Kuwahara M; Inoshita S; Terada Y; Sasaki S
Ther Apher Dial; 2009 Feb; 13(1):42-8. PubMed ID: 19379169
[TBL] [Abstract][Full Text] [Related]
13. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
14. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis.
Parfitt AM
Metabolism; 1976 Oct; 25(10):1157-88. PubMed ID: 787723
[TBL] [Abstract][Full Text] [Related]
15. The effect of parathyroid hormone (PTH) and 24,25-dihydroxy-vitamin D3 on adenylyl cyclase of iliac crest biopsies: diagnostic and prognostic tool for evaluation and treatment of uremic patients.
Gordeladze JO; Mortensen B; Nordal K; Halse J; Dahl E; Aksnes L; Gautvik KM
Scand J Clin Lab Invest Suppl; 1987; 186():13-20. PubMed ID: 3496656
[TBL] [Abstract][Full Text] [Related]
16. Serum osteoprotegerin and renal osteodystrophy.
Coen G; Ballanti P; Balducci A; Calabria S; Fischer MS; Jankovic L; Manni M; Morosetti M; Moscaritolo E; Sardella D; Bonucci E
Nephrol Dial Transplant; 2002 Feb; 17(2):233-8. PubMed ID: 11812872
[TBL] [Abstract][Full Text] [Related]
17. Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats.
Szabó A; Freesmeyer MG; Abendroth K; Stein G; Rosivall L; El-Shakmak A; Ritz E
Eur J Clin Invest; 1999 Jun; 29(6):529-35. PubMed ID: 10354215
[TBL] [Abstract][Full Text] [Related]
18. Long-term administration of vitamin D3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats.
Mortensen B; Gordeladze JO; Aksnes L; Gautvik KM
Calcif Tissue Int; 1990 May; 46(5):339-45. PubMed ID: 2159835
[TBL] [Abstract][Full Text] [Related]
19. Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease.
Jara A; Felsenfeld AJ; Bover J; Kleeman CR
Kidney Int; 2000 Sep; 58(3):1023-32. PubMed ID: 10972667
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
